Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Enlivex Therapeutics Ltd. Delisting Announcement 2026

Apr 5, 2026

6778_rns_2026-04-05_17dfbec8-a80a-4f89-9c8c-97a94152b924.pdf

Delisting Announcement

Open in viewer

Opens in your device viewer

הבורסה לניירות ערך תל אביב
TEL AVIV STOCK EXCHANGE

April 5, 2026
467533.docx

To: TASE Members

Dear Sir/Madam,

Re: ENLIVEX THERAPEUTICS LTD

Following our circular dated January 25, 2026, we would like to remind you that the company's shares (ISIN No. IL0011319527) will be delisted from TASE on April 26, 2026.

The last trading date in the Company's shares on TASE will be April 23, 2026.

The Company's shares will continue trading on NASDAQ.

Sincerely,

(-)

Listing Companies Compliance Unit

THE TEL-AVIV STOCK EXCHANGE LTD
2 Ahuzat Bayit St., Tel-Aviv 6525216 Israel • POB 29060, Tel-Aviv 6129001 Israel
Tel: 972-76-8160411 • Fax: 972-3-5105379
www.tase.co.il